What contributes to quality of life in patients with Parkinson's disease?
about
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's diseaseCognitive training interventions for dementia and mild cognitive impairment in Parkinson’s DiseaseTranscranial direct current stimulation (tDCS) for improving health -related quality of life, disability and impairment in patients with idiopathic Parkinson's diseaseTreatment of dementia in Parkinson's diseaseTherapies for depression in Parkinson's diseaseDance as therapy for individuals with Parkinson diseaseHealth related quality of life in Parkinson's disease: a systematic review of disease specific instrumentsTranscranial direct current stimulation (tDCS) for idiopathic Parkinson's diseaseValue and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness AnalysisAdult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticityApathy, Novelty Processing, and the P3 Potential in Parkinson's Disease.Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsNeurotrophic factors as a therapeutic target for Parkinson's diseaseDesipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neuronsThe role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyWhat is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders.The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Verbal Auditory Cueing of Improvisational Dance: A Proposed Method for Training Agency in Parkinson's Disease.More than just dancing: experiences of people with Parkinson's disease in a therapeutic dance program.Walking with music is a safe and viable tool for gait training in Parkinson's disease: the effect of a 13-week feasibility study on single and dual task walking.Fall frequency and risk assessment in early Parkinson's diseaseTreatment of advanced Parkinson's diseaseParkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognitionRandomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014).Demographic study of parkinson's disease in Iran: Data on 1656 casesCognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry.Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'Is Decompressive Surgery for Cervical Spondylotic Myelopathy Effective in Patients Suffering from Concomitant Multiple Sclerosis or Parkinson's Disease?The association between fear of falling and quality of life for balance impairments based on hip and ankle strategies in the drug On- and Off-phase of patients with idiopathic Parkinson' diseaseThe impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseScreening for impaired cognitive domains in a large Parkinson's disease population and its application to the diagnostic procedure for Parkinson's disease dementia.Behavioral phenotyping of mouse models of Parkinson's disease.Determinants of generic and specific health-related quality of life in patients with Parkinson's diseaseParkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effectsActivities of daily living, depression, and quality of life in Parkinson's disease.The spectrum of cognitive impairment in Lewy body diseases
P2860
Q21131896-97BD93E8-93EC-400B-B8A2-C1EA41962FFEQ24188194-58625227-5039-44B2-81E3-91CCC69A0B57Q24201496-74EBD997-8A30-49D4-A626-EEAFD86444C7Q24246868-C83391CE-8318-4BE3-A872-772910C50B2FQ24248733-45E9D76F-A4E6-4AA3-9AF1-1E4BBEFD6090Q24653440-F02249DA-89E0-4E89-9351-8B3BEC1222C0Q24672402-9051DF28-7E64-4A1D-8244-8D7D7D52DC46Q26471077-551D1DD7-B223-4D5B-B3C3-8140957CD185Q26752735-FAAD5DDD-C247-422B-ADD1-7FF6FD69B7C9Q26779605-ECCC14A3-D825-4447-AC43-307285BE82F7Q26862840-DDE1B96B-5560-4247-9218-F945E6F4F62EQ27318295-4D9C6889-BEC5-4CC5-8242-60C9F98915B3Q27691373-1240BEBB-16B6-4317-B498-87754CEE1BD2Q28273071-F27D371E-6EB5-4232-97E0-F0E251DD1863Q28485344-33091EC6-96C6-41B6-AC64-8C3DFAEF221BQ28727519-B54E5868-64DE-475E-B757-921A0F8D7E6DQ30240282-3DA3706A-B729-432D-91ED-8AD86E0689F4Q30248922-E449B335-BCB1-4F79-A6AD-D61D4FE6E820Q30385031-7CC8900D-4CB5-4570-8275-284B05AEE3CAQ30388429-DA5656EE-40B2-44B2-A63E-76E4D1B34A7EQ30395283-873C961A-57FC-4F7D-A99C-928DA1F86C61Q30418009-F2ED3CB3-84D5-4ABD-A441-CCCB71A865D0Q30476968-D7F1FEDD-8010-45E3-B23F-9CD5C7455A99Q30482965-E80C1119-A887-49C6-9409-26B80C33055BQ30518806-79EB97CF-EE45-4D35-8AD6-DC1E865D73DEQ30612675-3112522D-4B3E-4BFE-AB2F-8851DB7E12EAQ30697523-BF516374-4D08-4706-B0A5-6C98B37179BFQ30975753-FB82144C-DE18-413F-AFD9-C338BF5A4B2DQ33260251-6322F3D7-4C05-46B8-B229-F2388FAD5416Q33607919-A875B5BE-1DF5-4BD7-99B8-AC1CF0491B68Q33642301-AC134C73-2638-4FC8-B0E3-5D817510EB06Q33642311-43970060-B5A5-4332-AE8E-90FD53E0C06DQ33647691-7F97CF49-90DA-427A-B126-C179F1C4601DQ33795176-4305793A-709C-429E-B39D-4A1129503289Q33820609-F8638A35-C7D2-4891-8DE9-1AA3886DAB67Q33834634-36696672-2519-4293-A5D3-A70179202B7BQ33874635-1E91DF59-F120-478E-B994-A67947834C18Q33885120-2D6BF0C3-3E8A-441F-AA41-8D009682989AQ33905474-5BCCE4F4-1E27-4E9C-8744-76CA5FE91A46Q34019751-C78E6556-19DD-414B-8305-EEC683348EA8
P2860
What contributes to quality of life in patients with Parkinson's disease?
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
What contributes to quality of life in patients with Parkinson's disease?
@ast
What contributes to quality of life in patients with Parkinson's disease?
@en
type
label
What contributes to quality of life in patients with Parkinson's disease?
@ast
What contributes to quality of life in patients with Parkinson's disease?
@en
prefLabel
What contributes to quality of life in patients with Parkinson's disease?
@ast
What contributes to quality of life in patients with Parkinson's disease?
@en
P2093
P2860
P356
P1476
What contributes to quality of life in patients with Parkinson's disease?
@en
P2093
P2860
P304
P356
10.1136/JNNP.69.3.308
P407
P577
2000-09-01T00:00:00Z